Search for Clinical Trial Results
Membranous Nephropathy - 29 Studies Found
Status | Study |
Withdrawn |
Study Name: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy Condition: Glomerulonephritis, Membranous Date: 2013-01-04 Interventions:
|
Not yet recruiting |
Study Name: Study on the Therapeutic Effect of TCM Treatment for MDR MN Condition: Idiopathic Membranous Nephropathy Date: 2015-11-18 Interventions: Drug: Jianpixiaozhong particles and Wuse Dietotherapy Jianpixiaozhong particles: Three packs once,bid po |
Completed |
Study Name: Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental Condition:
Date: 2006-11-27 Interventions: |
Completed |
Study Name: Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome Condition:
Date: 2006-08-09 Interventions: Drug: tacrolimus combined with prednisone |
Completed |
Study Name: Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy Condition:
Date: 2002-12-17 Interventions: Drug: Sirolimus |
RECRUITING |
Study Name: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy Condition: Date: 2024-05-18 |
NOT_YET_RECRUITING |
Study Name: REmission in Membranous Nephropathy International Trial (REMIT) Condition: Primary Membranous Nephropathy Date: 2024-05-18 Interventions: Participants will receive an intravenous infusion of 1,000mg Obinutuzumab at Weeks 0, 2, 24 and 26.Prior to the administration of obinutuzum |
RECRUITING |
Study Name: A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy Condition: Primary Membranous Nephropathy Date: 2024-05-18 Interventions: Participants will receive zanubrutinib once daily |
RECRUITING |
Study Name: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy Condition: Primary Membranous Nephropathy Date: 2024-05-18 Interventions: Subjects will be randomly assigned in 1:1 treatment allocation ratio to receive the test and reference product. |